Kymab Limited
Other professional, scientific and technical activities n.e.c. · Cambridge
ActiveUnited KingdomIncorporated 2009Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
No processed account filings
No processed accounts are available in our records.
Registered details
07027523- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2009-09-23
- Jurisdiction
- —
- Registered office
- THE EDDEVA BUILDING (B920), BABRAHAM RESEARCH CAMPUS, CAMBRIDGE, CB22 3AT, ENGLAND
Classification
1 SIC codes74909
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
3 matched grantsCombining biophysical analysis and computational methods to understand critical molecular attributesEPSRC · Studentship · 2021-09-30 – 2025-09-29 · with 1 other participant£0whole project
Combining biophysical analysis and computational methods to understand critical molecular attributes
EPSRC · Studentship · 2021-09-30 – 2025-09-29 · with 1 other participant
£0
whole project
University College LondonleadKymab Limited
Computational methods for rapid structural modelling of antigen-antibody interactions to improve identification of antigen-specific antibodies from IgMRC · Studentship · 2018-09-30 – 2022-09-29 · with 1 other participant£0whole project
Computational methods for rapid structural modelling of antigen-antibody interactions to improve identification of antigen-specific antibodies from Ig
MRC · Studentship · 2018-09-30 – 2022-09-29 · with 1 other participant
£0
whole project
University Of OxfordleadKymab Limited
MICA: Developing novel human antibodies targeting the OPG/TRAIL axis for the treatment of pulmonary arterial hypertension (PAH)MRC · Research Grant · 2014-05-30 – 2016-11-30 · with 2 other participants£560,510whole project
MICA: Developing novel human antibodies targeting the OPG/TRAIL axis for the treatment of pulmonary arterial hypertension (PAH)
MRC · Research Grant · 2014-05-30 – 2016-11-30 · with 2 other participants
£560,510
whole project